You or a loved on have COVID? Be informed on the Monoclonal Antibody Infusion Treatments available.

Published September 3, 2021

Over the last year, frontline doctors through the US and worldwide have demonstrated that C-19 “early treatment” significantly reduces serious illness and death. While supplements like Quercetin, Vitamins C, B and D3, Zinc, Magnesium, which are well known to boost the body’s natural immune system are very effective, Washington bureaucrats, who are basically controlled by the big pharmaceutical companies, have refused to recognize these safe, inexpensive, and effective therapeutics in the fight against C-19. While the bureaucrats have persistently offered no preventative or early intervention therapeutics, they have pushed the ineffective and dangerous drug Remdesivir once a person has been hospitalized.

However, one experimental drug that has received FDA Emergency Use Authorization (EUA) is Regeneron, a monoclonal antibody. The approval is only for out-patient treat during the first ten days of symptoms.

Texas has been quietly making this treatment available for several months through Infusion Centers, but because there has been little to no public promotion of these centers, few Texans are aware of their existence.

The purpose of this post is to make as many Texans as possible aware of this FDA approved early treatment and provide the information.

The FDA has granted Emergency Use Authorization (EUA) for two new treatments for C-19. These treatments are what is referred to as monoclonal antibodies, and both have been authorized to treat non-hospitalized adults and children 12 years of age and older.

Monoclonal antibodies are laboratory-produced molecules that act as substitute antibodies to restore, enhance, or mimic the immune system’s function to attack foreign cells, in this case the C-19 virus. These treatments attack a C-19 protein making it more difficult for the virus to attach to and enter human cells.

These treatments are designed for non-hospitalized adults and children who have recently tested positive for C-19, are within 10 days of symptom onset, and are at high risk for progressing to severe C-19 and/or hospitalization.

To request infusion of monoclonal antibodies and a medical team at your facility, you may call the 24-hour State Infusion Hotline at 1-800-742-5990 or go to the web site meds.tdem.Texas.gov.

I am honored to have my good friend and Liberty 8 classmate, Senator Lois Kolkhorst, Senate Health and Human Services Chair with me today to help explain the Infusion Center service and how Texans can receive C-19 early treatment at no direct cost to them.

Loading comments...
BREAKING NEWS: Rumble Announces A Major Step Towards Merging with NASDAQ: $CFVI